BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

GW Medical Technologies, LLC's New Blood Test For Alzheimer's Disease Seeks Future Test Candidates; Patients And Physicians Needed For Breakthrough Test


10/19/2005 5:10:15 PM

PHOENIX--(BUSINESS WIRE)--May 11, 2005--GW Medical Technologies LLC, the worldwide technology provider of the blood test for Alzheimer's disease (AD) known as the LymPro(TM) Test, announces a nationwide online registration of Alzheimer's patients, caregivers and physicians who want to become involved in upcoming clinical studies for this breakthrough diagnostic blood test for Alzheimer's disease. Those individuals who are interested in participating in future clinical studies can register by going to the company Web site at www.GWmedtech.com. The online registration takes less than one minute to complete. As new clinical studies are launched, those who sign up as interested parties will be contacted first with complete study details and requirements. These studies will be part of the FDA Pre-market Approval (PMA) process for the LymPro Test, which the company is planning to submit to the FDA within the near future.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->